Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus - Université de Reims Champagne-Ardenne Access content directly
Journal Articles JAMA Dermatology Year : 2018

Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus

Domains

Human health and pathology Immunology

Arnaud Pommier  : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03604981

Submitted on : Thursday, March 10, 2022-5:08:31 PM

Last modification on : Friday, March 11, 2022-3:12:36 AM

Consult the full text

Dates and versions

hal-03604981 , version 1 (10-03-2022)

Identifiers

Cite

Julia Sanchez, Saskia Ingen-Housz-Oro, Olivier Chosidow, Frank Antonicelli, Philippe Bernard. Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus. JAMA Dermatology, 2018, 154 (3), pp.363. ⟨10.1001/jamadermatol.2017.5176⟩. ⟨hal-03604981⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

URCA IRMAIC
2 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More